Mar 08, 2022 / 07:50PM GMT
Kenneth Charles Cacciatore - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Okay. Great. Thanks, everyone, for joining the Takeda fireside chat. We're really thrilled to have Andy and Ramona. Andy is President of R&D; and Ramona, President of the Global Portfolio Commercialization. So really fun discussion. I know offline, but always helping us is [Novi, Elizabeth and Sumi]. So we're really appreciative to them and all the help that they give us.
Questions and Answers:
Kenneth Charles Cacciatore - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystWhere we thought we'd start, Ramona, is one of the most interesting components of Takeda, I shouldn't say interesting, I think one of the things when you first start looking at and analyzing as an outsider like we did was there are a few exclusivities that are out there, some that are just certain like VYVANSE. There's nothing we can do about it and it's understood. And we understood the hemophilia portfolio and kind of the pressures.
But one